2025/07/29 更新

所属以外の情報はresearchmapへの登録情報を転載しています。

写真a

イシイ　ミオ
石井 美緒
Mio Ishii
所属
附属病院 精神科 助教
職名
助教
プロフィール
  • 臨床精神科医としての専門は精神科救急、児童思春期です。
  • 主に精神科救急の現場で、当事者中心の医療、行動制限最小化に向けた臨床研究を行っています。
  • 現在は行政医として地域包括ケアシステムにおける精神科救急の仕組み作り、自治体における若者メンタルヘルス支援に取り組んでいます。
外部リンク

学位

  • 博士（医学） （ 2017年3月   横浜市立大学医学部大学院 ）

  • 学士（医学） （ 2007年3月   札幌医科大学医学部医学科 ）

研究キーワード

  • 行動制限最小化

  • Digital Psychiatry

  • Person Centered Care

  • トラウマインフォームドケア

  • 児童思春期精神医療

  • 精神科救急

研究分野

  • ライフサイエンス / 精神神経科学

経歴

  • 横浜市立大学附属病院精神科

    2025年4月 - 現在

    　 詳細を見る

  • 横浜市立大学附属病院児童精神科

    2022年10月 - 現在

    　 詳細を見る

  • 川崎市健康福祉局総合リハビリテーション推進センター

    2020年4月 - 2025年3月

    　 詳細を見る

  • 横浜市立大学附属病院精神科

    2016年4月 - 2020年3月

    　 詳細を見る

  • 横浜市立大学大学院医学研究科医科学専攻

    2011年4月 - 2017年3月

    　 詳細を見る

  • 公益財団法人復康会 沼津中央病院

    2011年4月 - 2016年3月

    　 詳細を見る

  • 横浜市立大学市民総合医療センター

    2009年4月 - 2011年3月

    　 詳細を見る

▼全件表示

所属学協会

論文

  • Insights From the Nihon Housou Kyoukai’s Virtual Reality–Based Social Interaction Television Program “Project Aliens” for Adolescents With Psychiatric Disorders: Single-Center Case Series Study

    Junichi Fujita, Mizuho Takayama, Emi Kamono, Satoru Shinoda, Hiroyuki Yamaguchi, Tomoko Moroga, Mio Ishii, Tomoyuki Miyazaki

    JMIR Formative Research   2025年5月

    　詳細を見る

    掲載種別：研究論文（学術雑誌）  

    DOI： 10.2196/74401

    researchmap

  • Insights From the Nihon Housou Kyoukai’s Virtual Reality–Based Social Interaction Television Program “Project Aliens” for Adolescents With Psychiatric Disorders: Single-Center Case Series Study (Preprint)

    Junichi Fujita, Mizuho Takayama, Emi Kamono, Satoru Shinoda, Hiroyuki Yamaguchi, Tomoko Moroga, Mio Ishii, Tomoyuki Miyazaki

    2025年4月

    　詳細を見る

  • Challenges in Implementing a Mobile AI Chatbot Intervention for Depression Among Youth on Psychiatric Waiting Lists: A Randomized Control Study Termination Report

    Junichi Fujita, Yuichiro Yano, Satoru Shinoda, Noriko Sho, Masaki Otsuki, Akira Suda, Mizuho Takayama, Tomoko Moroga, Hiroyuki Yamaguchi, Mio Ishii, Tomoyuki Miyazaki

    2024年11月

    　詳細を見る

  • Feasibility and efficacy of shared decision making for first-admission schizophrenia: a randomized clinical trial. 国際誌

    Mio Ishii, Yasuyuki Okumura, Naoya Sugiyama, Hana Hasegawa, Toshie Noda, Yoshio Hirayasu, Hiroto Ito

    BMC psychiatry   17 ( 1 )   52 - 52   2017年2月

    　詳細を見る

    記述言語：英語   掲載種別：研究論文（学術雑誌）  

    BACKGROUND: The feasibility of shared decision making (SDM) for patients with schizophrenia remains controversial due to the assumed inability of patients to cooperate in treatment decision making. This study evaluated the feasibility and efficacy of SDM in patients upon first admission for schizophrenia. METHODS: This was a randomized, parallel-group, two-arm, open-label, single-center study conducted in an acute psychiatric ward of Numazu Chuo Hospital, Japan. Patients with the diagnosis of schizophrenia upon their first admission were randomized into a SDM intervention group or a usual treatment group in a 1:1 ratio. The primary outcome was patient satisfaction at discharge. The secondary outcomes were attitudes toward medication at discharge and treatment continuation at 6 months after discharge. RESULTS: Twenty-four patients were randomly assigned. The trial was prematurely terminated due to slow enrollment. At discharge, the mean score on satisfaction was 23.7 in the SDM group and 22.1 in the usual care group (unadjusted mean difference: 1.6; 95% CI: -5.2 to 2.0). Group differences were not observed in attitude toward medication and treatment continuation. There was no statistically significant difference between the groups for the mean Global Assessment of Functioning score at discharge or length of stay as safety endpoint. CONCLUSIONS: No statistical differences were found between the SDM group and usual care group in the efficacy outcomes and safety endpoints. Large trials are needed to confirm the efficacy of the SDM program upon first admission for schizophrenia. TRIAL REGISTRATION: The study has been registered with ClinicalTrials.gov as NCT01869660 (registered 27 May, 2013).

    DOI： 10.1186/s12888-017-1218-1

    PubMed

    researchmap

  • Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial. 国際誌

    Mio Ishii, Yasuyuki Okumura, Naoya Sugiyama, Hana Hasegawa, Toshie Noda, Yoshio Hirayasu, Hiroto Ito

    BMC psychiatry   14   111 - 111   2014年4月

    　詳細を見る

    記述言語：英語   掲載種別：研究論文（学術雑誌）  

    BACKGROUND: Shared decision making is a promising model for patient-centred medicine, resulting in better clinical outcomes overall. In the mental health field, interventions that consider the patient-centred perspective--such as patient quality of life, involvement in the treatment, treatment satisfaction, and working alliance--have increased and better clinical outcomes discovered for patients with schizophrenia. However, few studies have examined the efficacy of shared decision making for schizophrenia treatment. The objective of this study is to evaluate the effect of a shared decision making intervention compared to treatment as usual on patient satisfaction at discharge for first-admission patients with schizophrenia. METHODS/DESIGN: This is a randomised, parallel-group, two-arm, open-label, single-centre study currently being conducted in an acute psychiatric ward of Numazu Chuo Hospital, Japan. We are recruiting patients between 16 and 65 years old who are admitted to the ward with a diagnosis of schizophrenia without prior experience of psychiatric admission. Fifty-eight participants are being randomised into a shared decision making intervention group or a treatment as usual control group in a 1:1 ratio. The intervention program was developed based on a shared decision making model and is presented as a weekly course lasting the duration of the patients' acute psychiatric ward stay. The primary outcome measure is patient satisfaction at discharge as assessed by the Client Satisfaction Questionnaire. Due to the study's nature, neither the patient nor staff can be blinded. DISCUSSION: This is the first randomised controlled trial to evaluate the efficacy of shared decision making for patients with early-treatment-stage schizophrenia. The intervention program in this study is innovative in that it includes both of the patient and staff who are involved in the treatment. TRIAL REGISTRATION: The study has been registered with ClinicalTrials.gov as NCT01869660.

    DOI： 10.1186/1471-244X-14-111

    PubMed

    researchmap

MISC

▼全件表示